Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 3/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.30 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.30 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.30 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.30 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3884352 | 1.00 | PGK1 (0.33) | PGK1PGK2PGDMPIATM | |
| SCHEMBL541862 | 0.92 | ATM (0.35) | PGK1PGK2ATMLPAR6LPAR1 | |
| SCHEMBL20378001 | 0.91 | ATM (0.34) | ATMLPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL20505229 | 0.90 | LPAR3 (0.31) | ATMGSTP1LPAR1LPAR2LPAR3 | |
| SCHEMBL19614684 | 0.90 | HCAR2 (0.35) | ATMLPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL20378027 | 0.90 | HCAR2 (0.35) | ATMLPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL20378002 | 0.86 | ATM (0.32) | PGK1PGK2ATMLPAR6LPAR1 | |
| SCHEMBL20378040 | 0.86 | PGK1 (0.31) | PGK1PGK2 | |
| SCHEMBL20338139 | 0.84 | TSHR (0.40) | PGK1PGK2PGDMPILPAR6 | |
| SCHEMBL20378036 | 0.84 | ATM (0.33) | ATMLPAR6LPAR1LPAR4LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220227954-A1 | POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | OAKTREE FUND ADMINISTRATION, LLC | 2022-07-21 | — | — | US | claimed |
| EP-3862384-A2 | POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | SiO2 Medical Products, Inc. (US) | 2021-08-11 | — | — | EP | claimed |
| US-20220227954-A1 | POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | OAKTREE FUND ADMINISTRATION, LLC | 2022-07-21 | — | — | US | disclosed |
| US-11248100-B2 | Polymeric surface having reduced biomolecule adhesion to thermoplastic articles of such substrate | SIO2 MEDICAL PRODUCTS, INC (US) | 2022-02-15 | — | — | US | disclosed |
| EP-3862384-A2 | POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | SiO2 Medical Products, Inc. (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20180334545-A1 | POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | OAKTREE FUND ADMINISTRATION, LLC | 2018-11-22 | — | — | US | disclosed |
| EP-3377565-A1 | POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | SiO2 Medical Products, Inc. (US) | 2018-09-26 | — | — | EP | disclosed |
| EP-1245636-B1 | COMPOSITION FOR HYDROGEL, HYDROGEL, AND USE THEREOF | NOF CORP (JP) | 2009-01-14 | — | — | EP | disclosed |
| EP-1206946-B1 | MEDICAL MATERIALS AND PROCESS FOR PRODUCING THE SAME | NOF CORP (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-6858673-B1 | Composition for hydrogel, hydrogel and use thereof | NOF CORPORATION (JP) | 2005-02-22 | — | — | US | disclosed |
| EP-0947244-B1 | SOLUBILIZERS, EMULSIFIERS AND DISPERSANTS | NOF CORP (JP) | 2004-12-29 | — | — | EP | disclosed |
| US-6828028-B1 | Having surface treated with copolymer of such as ring opened glycidyl methacrylate and 2-(methacryloyloxy)ethyl-2-(tri-methylammonio)ethylphosphate; lubricity, blood compatible, safe, stable, durable | NOF CORPORATION (JP) | 2004-12-07 | — | — | US | disclosed |
| US-6503632-B1 | Siloxane polymers typified by polydimethylsiloxane have excellent biocompatibility, gas permeability, etc. alkylamide groups impart strength; medical equipment | NOF CORPORATION (JP) | 2003-01-07 | — | — | US | disclosed |
| EP-1245636-A1 | COMPOSITION FOR HYDROGEL, HYDROGEL, AND USE THEREOF | NOF CORPORATION (JP) | 2002-10-02 | — | — | EP | disclosed |
| EP-1206946-A1 | MEDICAL MATERIALS AND PROCESS FOR PRODUCING THE SAME | NOF CORPORATION (JP) | 2002-05-22 | — | — | EP | disclosed |
| EP-1116740-A1 | POLYDIALKYLSILOXANE / POLYAMIDE COPOLYMER, PROCESS FOR PRODUCING THE SAME, AND VARIOUS MATERIALS | NOF CORPORATION (JP) | 2001-07-18 | — | — | EP | disclosed |
| US-6214957-B1 | POLYMER CONTAINING HYDROPHILIC MONOMERS HAVING AMMONIO ETHYL PHOSPHATE SIDE CHAINS, POLYMER IS SOLUBLE IN SOLVENT CONTAINING WATER | NOF CORPORATION (JP) | 2001-04-10 | — | — | US | disclosed |
| US-5977257-A | Polymer material, medical material and liquid high molecular composition | NOF CORPORATION (JP) | 1999-11-02 | — | — | US | disclosed |
| EP-0947244-A1 | SOLUBILIZERS, EMULSIFIERS AND DISPERSANTS | NOF CORPORATION (JP) | 1999-10-06 | — | — | EP | disclosed |
| EP-0823458-A1 | POLYMERIC MATERIAL, MEDICAL MATERIAL AND LIQUID POLYMER COMPOSITION | NOF CORPORATION (JP) | 1998-02-11 | — | — | EP | disclosed |